» Articles » PMID: 34949203

Microglia and Astrocyte Involvement in Neurodegeneration and Brain Cancer

Overview
Publisher Biomed Central
Date 2021 Dec 24
PMID 34949203
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The brain is unique and the most complex organ of the body, containing neurons and several types of glial cells of different origins and properties that protect and ensure normal brain structure and function. Neurological disorders are the result of a failure of the nervous system multifaceted cellular networks. Although great progress has been made in the understanding of glia involvement in neuropathology, therapeutic outcomes are still not satisfactory. Here, we discuss recent perspectives on the role of microglia and astrocytes in neurological disorders, including the two most common neurodegenerative conditions, Alzheimer disease and progranulin-related frontotemporal lobar dementia, as well as astrocytoma brain tumors. We emphasize key factors of microglia and astrocytic biology such as the highly heterogeneic glial nature strongly dependent on the environment, genetic factors that predispose to certain pathologies and glia senescence that inevitably changes the CNS landscape. Our understanding of diverse glial contributions to neurological diseases can lead advances in glial biology and their functional recovery after CNS malfunction.

Citing Articles

pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of ALS/FTD patients.

Wang H, Xiang J, Yuan C, Veire A, Gendron T, Murray M Proc Natl Acad Sci U S A. 2025; 122(9):e2419818122.

PMID: 39999167 PMC: 11892677. DOI: 10.1073/pnas.2419818122.


The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile.

Germelli L, Angeloni E, Da Pozzo E, Tremolanti C, De Felice M, Giacomelli C Cell Mol Life Sci. 2025; 82(1):34.

PMID: 39757281 PMC: 11700965. DOI: 10.1007/s00018-024-05544-1.


Association between microenvironment-related genes and prognosis of primary central nervous system lymphoma.

Hattori K, Makishima K, Suma S, Abe Y, Suehara Y, Sakamoto T EJHaem. 2024; 5(6):1201-1214.

PMID: 39691244 PMC: 11647707. DOI: 10.1002/jha2.1046.


The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings.

Yang J, Liang J, Hu N, He N, Liu B, Liu G CNS Neurosci Ther. 2024; 30(10):e70091.

PMID: 39460538 PMC: 11512114. DOI: 10.1111/cns.70091.


References
1.
Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J . Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004; 10(7):719-26. DOI: 10.1038/nm1058. View

2.
Dzaye O, Hu F, Derkow K, Haage V, Euskirchen P, Harms C . Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling. J Neuropathol Exp Neurol. 2016; 75(5):429-40. PMC: 5009477. DOI: 10.1093/jnen/nlw016. View

3.
Deleidi M, Jaggle M, Rubino G . Immune aging, dysmetabolism, and inflammation in neurological diseases. Front Neurosci. 2015; 9:172. PMC: 4453474. DOI: 10.3389/fnins.2015.00172. View

4.
Wauters E, Van Mossevelde S, van der Zee J, Cruts M, Van Broeckhoven C . Modifiers of GRN-Associated Frontotemporal Lobar Degeneration. Trends Mol Med. 2017; 23(10):962-979. DOI: 10.1016/j.molmed.2017.08.004. View

5.
Li Q, Cheng Z, Zhou L, Darmanis S, Neff N, Okamoto J . Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron. 2019; 101(2):207-223.e10. PMC: 6336504. DOI: 10.1016/j.neuron.2018.12.006. View